Cargando…

The anti-addiction drug ibogaine inhibits cardiac ion channels: a study to assess the drug’s proarrhythmic potential

Detalles Bibliográficos
Autores principales: Koenig, Xaver, Kovar, Michael, Rubi, Lena, Mike, Ágnes K, Lukács, Péter, Gawali, Vaibhavkumar S, Todt, Hannes, Sandtner, Walter, Hilber, Karlheinz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3506296/
http://dx.doi.org/10.1186/2050-6511-13-S1-A38
_version_ 1782250883652780032
author Koenig, Xaver
Kovar, Michael
Rubi, Lena
Mike, Ágnes K
Lukács, Péter
Gawali, Vaibhavkumar S
Todt, Hannes
Sandtner, Walter
Hilber, Karlheinz
author_facet Koenig, Xaver
Kovar, Michael
Rubi, Lena
Mike, Ágnes K
Lukács, Péter
Gawali, Vaibhavkumar S
Todt, Hannes
Sandtner, Walter
Hilber, Karlheinz
author_sort Koenig, Xaver
collection PubMed
description
format Online
Article
Text
id pubmed-3506296
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-35062962012-11-29 The anti-addiction drug ibogaine inhibits cardiac ion channels: a study to assess the drug’s proarrhythmic potential Koenig, Xaver Kovar, Michael Rubi, Lena Mike, Ágnes K Lukács, Péter Gawali, Vaibhavkumar S Todt, Hannes Sandtner, Walter Hilber, Karlheinz BMC Pharmacol Toxicol Meeting Abstract BioMed Central 2012-09-17 /pmc/articles/PMC3506296/ http://dx.doi.org/10.1186/2050-6511-13-S1-A38 Text en Copyright ©2012 Koenig et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Meeting Abstract
Koenig, Xaver
Kovar, Michael
Rubi, Lena
Mike, Ágnes K
Lukács, Péter
Gawali, Vaibhavkumar S
Todt, Hannes
Sandtner, Walter
Hilber, Karlheinz
The anti-addiction drug ibogaine inhibits cardiac ion channels: a study to assess the drug’s proarrhythmic potential
title The anti-addiction drug ibogaine inhibits cardiac ion channels: a study to assess the drug’s proarrhythmic potential
title_full The anti-addiction drug ibogaine inhibits cardiac ion channels: a study to assess the drug’s proarrhythmic potential
title_fullStr The anti-addiction drug ibogaine inhibits cardiac ion channels: a study to assess the drug’s proarrhythmic potential
title_full_unstemmed The anti-addiction drug ibogaine inhibits cardiac ion channels: a study to assess the drug’s proarrhythmic potential
title_short The anti-addiction drug ibogaine inhibits cardiac ion channels: a study to assess the drug’s proarrhythmic potential
title_sort anti-addiction drug ibogaine inhibits cardiac ion channels: a study to assess the drug’s proarrhythmic potential
topic Meeting Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3506296/
http://dx.doi.org/10.1186/2050-6511-13-S1-A38
work_keys_str_mv AT koenigxaver theantiaddictiondrugibogaineinhibitscardiacionchannelsastudytoassessthedrugsproarrhythmicpotential
AT kovarmichael theantiaddictiondrugibogaineinhibitscardiacionchannelsastudytoassessthedrugsproarrhythmicpotential
AT rubilena theantiaddictiondrugibogaineinhibitscardiacionchannelsastudytoassessthedrugsproarrhythmicpotential
AT mikeagnesk theantiaddictiondrugibogaineinhibitscardiacionchannelsastudytoassessthedrugsproarrhythmicpotential
AT lukacspeter theantiaddictiondrugibogaineinhibitscardiacionchannelsastudytoassessthedrugsproarrhythmicpotential
AT gawalivaibhavkumars theantiaddictiondrugibogaineinhibitscardiacionchannelsastudytoassessthedrugsproarrhythmicpotential
AT todthannes theantiaddictiondrugibogaineinhibitscardiacionchannelsastudytoassessthedrugsproarrhythmicpotential
AT sandtnerwalter theantiaddictiondrugibogaineinhibitscardiacionchannelsastudytoassessthedrugsproarrhythmicpotential
AT hilberkarlheinz theantiaddictiondrugibogaineinhibitscardiacionchannelsastudytoassessthedrugsproarrhythmicpotential
AT koenigxaver antiaddictiondrugibogaineinhibitscardiacionchannelsastudytoassessthedrugsproarrhythmicpotential
AT kovarmichael antiaddictiondrugibogaineinhibitscardiacionchannelsastudytoassessthedrugsproarrhythmicpotential
AT rubilena antiaddictiondrugibogaineinhibitscardiacionchannelsastudytoassessthedrugsproarrhythmicpotential
AT mikeagnesk antiaddictiondrugibogaineinhibitscardiacionchannelsastudytoassessthedrugsproarrhythmicpotential
AT lukacspeter antiaddictiondrugibogaineinhibitscardiacionchannelsastudytoassessthedrugsproarrhythmicpotential
AT gawalivaibhavkumars antiaddictiondrugibogaineinhibitscardiacionchannelsastudytoassessthedrugsproarrhythmicpotential
AT todthannes antiaddictiondrugibogaineinhibitscardiacionchannelsastudytoassessthedrugsproarrhythmicpotential
AT sandtnerwalter antiaddictiondrugibogaineinhibitscardiacionchannelsastudytoassessthedrugsproarrhythmicpotential
AT hilberkarlheinz antiaddictiondrugibogaineinhibitscardiacionchannelsastudytoassessthedrugsproarrhythmicpotential